Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Small

Showing results (941-950 of 1,203) with videos related to

Pageof 121
Sort By:
The Journal of Clinical Investigation|April 5, 2000
The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptinM S Kim, C J Small, S A Stanley, et al.
The Journal of Urology|May 1, 1997
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockadeP F Schellhammer, P Venner, G P Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Efficacy and Safety Exposure-Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate CancerCarlos Perez-Ruixo, Oliver Ackaert, Daniele Ouellet, et al.
Psycho-Oncology|June 21, 2012
Effects of self-directed stress management training and home-based exercise on quality of life in cancer patients receiving chemotherapy: a randomized controlled trialPaul B Jacobsen, Kristin M Phillips, Heather S L Jim, et al.
Diabetes|October 27, 2001
Ghrelin causes hyperphagia and obesity in ratsA M Wren, C J Small, C R Abbott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trialRoy S Herbst, Anne-Marie Maddox, Mace L Rothenberg, et al.
Neuropsychiatry|November 1, 2013
Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response preventionJoseph F McGuire, Adam B Lewin, Daniel A Geller, et al.
Physiological Reports|April 12, 2019
Resistance to visceral obesity is associated with increased locomotion in mice expressing an endothelial cell-specific fibroblast growth factor 1 transgeneTyler Keeley, Aleksandr Kirov, Woon Yuen Koh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate CancerEric Lu, George V Thomas, Yiyi Chen, et al.
Cancer|October 16, 2004
Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480Tim A Ahles, James E Herndon, Eric J Small, et al.
Pageof 121

Showing results (941-950 of 1,203) with videos related to

Sort By:
Pageof 121
The Journal of Clinical Investigation|April 5, 2000
The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptinM S Kim, C J Small, S A Stanley, et al.
The Journal of Urology|May 1, 1997
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockadeP F Schellhammer, P Venner, G P Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Efficacy and Safety Exposure-Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate CancerCarlos Perez-Ruixo, Oliver Ackaert, Daniele Ouellet, et al.
Psycho-Oncology|June 21, 2012
Effects of self-directed stress management training and home-based exercise on quality of life in cancer patients receiving chemotherapy: a randomized controlled trialPaul B Jacobsen, Kristin M Phillips, Heather S L Jim, et al.
Diabetes|October 27, 2001
Ghrelin causes hyperphagia and obesity in ratsA M Wren, C J Small, C R Abbott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trialRoy S Herbst, Anne-Marie Maddox, Mace L Rothenberg, et al.
Neuropsychiatry|November 1, 2013
Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response preventionJoseph F McGuire, Adam B Lewin, Daniel A Geller, et al.
Physiological Reports|April 12, 2019
Resistance to visceral obesity is associated with increased locomotion in mice expressing an endothelial cell-specific fibroblast growth factor 1 transgeneTyler Keeley, Aleksandr Kirov, Woon Yuen Koh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate CancerEric Lu, George V Thomas, Yiyi Chen, et al.
Cancer|October 16, 2004
Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480Tim A Ahles, James E Herndon, Eric J Small, et al.
Pageof 121